According to the research report titled ‘North America COVID-19 Detection Kits Market Growth By Specimen Type, Product, End-use, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’ available with Market Study Report, North America COVID-19 detection kits market is anticipated to surpass USD 1.7 billion by the year 2026.
 

Factors such as increasing number of COVID-19 cases in U.S., rising prevalence of comorbid ailments such as diabetes and hypertension and growing geriatric population are leading to an upsurge in the demand for COVID-19 detection kits, which in turn is augmenting the growth of the market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2683095/
 

Furthermore, favorable government initiatives towards increasing the regional testing capacity in order to screen more individuals are further fueling the market expansion. On the contrary, rising concerns regarding low accuracy of immunoassay-based detection kits are expected to hamper the expansion of the market throughout the analysis timeframe.
 

Based on product terrain, the RT-PCR assay kits segment is predicted to register a CAGR of 21% during 2020-2026, owing to higher sensitivity as well as accuracy of the kits as compared to immunoassay-based kits.
 

With regards to specimen type, the oropharyngeal swab segment reflected around 28% market share in the year 2020 and is expected to show similar growth through 2026. Easy-to-use nature of the product along with high sensitivity for COVID-19 viruses are fueling the growth of the segment.
 

Moving on to the end-user spectrum, the hospital segment is projected to exhibit a robust CAGR of 17% over 2020-2026. Increasing number of patient admissions in hospitals for treatment and diagnosis of the Coronavirus due to availability of advanced equipment as well as trained professionals are fostering the growth of the segment.
 

Elaborating on the country-level analysis of the report, U.S. COVID-19 detection kits market is predicted to record a 21% CAGR through 2026, primarily due to rising number of COVID-19 cases along with high concentration of market players in the country.
 

The leading companies operating in North America COVID-19 Detection Kits market include Thermo Fisher Scientific Inc., QIAGEN, GenMark Diagnostics, Inc., F. Hoffmann-La Roche AG, Co-Diagnostics, Inc., Cepheid, BioFire Diagnostics LLC, and Abbott Laboratories among others.